These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33185588)

  • 1. Identification of MYLIP gene and miRNA-802 involved in the growth and metastasis of cervical cancer cells.
    Ni M; Yan Q; Xue H; Du Y; Zhao S; Zhao Z
    Cancer Biomark; 2021; 30(3):287-298. PubMed ID: 33185588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.
    Shen W; Xie XY; Liu MR; Wang LL
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1957-1968. PubMed ID: 30915738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA TUSC8 inhibits breast cancer growth and metastasis via miR-190b-5p/MYLIP axis.
    Zhao L; Zhou Y; Zhao Y; Li Q; Zhou J; Mao Y
    Aging (Albany NY); 2020 Feb; 12(3):2974-2991. PubMed ID: 32039833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules.
    Zhao L; Zhao Y; He Y; Mao Y
    Oncotarget; 2017 Sep; 8(38):64330-64343. PubMed ID: 28969074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.
    Kapora E; Feng S; Liu W; Sakhautdinova I; Gao B; Tan W
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31266812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
    Dai SG; Guo LL; Xia X; Pan Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
    Chen R; Gan Q; Zhao S; Zhang D; Wang S; Yao L; Yuan M; Cheng J
    BMC Cancer; 2022 May; 22(1):488. PubMed ID: 35505294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis.
    Liu J; Li Y; Chen X; Xu X; Zhao H; Wang S; Hao J; He B; Liu S; Wang J
    BMC Cancer; 2020 Oct; 20(1):1029. PubMed ID: 33109127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).
    Zhang W; Zhang M; Liu L; Jin D; Wang P; Hu J
    Med Sci Monit; 2018 Oct; 24():7137-7145. PubMed ID: 30293085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer.
    Chang QQ; Chen CY; Chen Z; Chang S
    Radiol Oncol; 2019 Oct; 53(4):443-452. PubMed ID: 31626590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9.
    Liu CQ; Chen Y; Xie BF; Li YL; Wei YT; Wang F
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5628-5639. PubMed ID: 31298315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
    Wang N; Zhou Y; Zheng L; Li H
    Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
    Xu YJ; Yu H; Liu GX
    J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
    Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
    Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells].
    Shi YR; Liu J; He W; Yang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):697-702. PubMed ID: 28598082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer.
    Xiao H; Yu L; Li F; Wang H; Li W; He X
    Cell Biol Int; 2018 Sep; 42(9):1115-1123. PubMed ID: 29660208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential suppressive functions of microRNA-504 in cervical cancer cells malignant process were achieved by targeting PAICS and regulating EMT.
    Qu ZY; Cui GY; Shi PJ; Wang HQ
    Arch Gynecol Obstet; 2020 Jul; 302(1):173-182. PubMed ID: 32417959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells.
    Huang F; Lin C; Shi YH; Kuerban G
    Asian Pac J Cancer Prev; 2013; 14(10):5915-20. PubMed ID: 24289600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.